Oruka Therapeutics, Inc. is a in vitro & in vivo diagnostic substances company on XNAS, led by Lawrence Klein, with a market cap of $1.5B. As of Q3 2025, 94% of shares are held by 104 institutional investors, with FMR LLC as the largest holder at 15.0%.
Overview of institutional ownership in ORKA as of Q3 2025 with a market cap of $930.4M
Based on market cap of $930.4M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Institutions with the largest positions in ORKA as of Q3 2025
| Institution | Position Value |
|---|---|
FMR LLC Institution | $139.6M 0.01% of portfolio |
VR Adviser, LLC Venture Capital | $79.8M 4.49% of portfolio |
Fairmount Funds Management LLC Hedge Fund•Sector | $71.3M 6.41% of portfolio |
VIKING GLOBAL INVESTORS LP Hedge Fund•Long/Short | $51.3M 0.13% of portfolio |
Deep Track Capital, LP Hedge Fund•Long/Short | $51.1M 1.45% of portfolio |
B BlackRock, Inc. Institution | $42.4M 0.00% of portfolio |
RTW INVESTMENTS, LLC Hedge Fund•Sector | $37.4M 0.46% of portfolio |
VANGUARD GROUP INC Institution | $34.2M 0.00% of portfolio |
COMMODORE CAPITAL LP Hedge Fund•Long/Short | $33.7M 1.65% of portfolio |
B BRAIDWELL LP Hedge Fund•Multi-Strategy | $26.6M 1.08% of portfolio |
Institutional buying and selling activity for ORKA in Q3 2025
| Institution | Net Bought |
|---|---|
VIKING GLOBAL INVESTORS LP Hedge Fund•Long/Short | +$51.3M +2.7M shares |
FMR LLC Institution | +$31.6M +1.6M shares |
venBio Select Advisor LLC RIA/Wealth | +$25.6M +1.3M shares |
PERCEPTIVE ADVISORS LLC Hedge Fund•Long/Short | +$24.4M +1.3M shares |
Deep Track Capital, LP Hedge Fund•Long/Short | +$14.2M +736.0K shares |
Point72 Asset Management, L.P. Hedge Fund•Multi-Strategy | +$13.6M +707.0K shares |
C Cormorant Asset Management, LLC Hedge Fund•Long/Short | +$10.3M +533.3K shares |
Affinity Asset Advisors, LLC Hedge Fund•Long/Short | +$6.8M +355.7K shares |
Fairmount Funds Management LLC Hedge Fund•Sector | +$6.4M +333.3K shares |
COMMODORE CAPITAL LP Hedge Fund•Long/Short | +$6.4M +333.3K shares |
| Institution | Net Sold |
|---|---|
Frazier Life Sciences Management, L.P. Venture Capital | −$6.5M −583.3K shares |
B BRAIDWELL LP Hedge Fund•Multi-Strategy | −$2.7M −142.5K shares |
A ADAR1 Capital Management, LLC Hedge Fund•Long/Short | −$2.3M −121.9K shares |
Cable Car Capital LLC Hedge Fund•Long/Short | −$1.9M −100.0K shares |
SILVERARC CAPITAL MANAGEMENT, LLC Hedge Fund•Long/Short | −$1.9M −165.4K shares |
MORGAN STANLEY RIA/Wealth | −$1.4M −73.5K shares |
GOLDMAN SACHS GROUP INC Institution | −$1.0M −52.5K shares |
VANGUARD GROUP INC Institution | −$781.5K −40.6K shares |
Ikarian Capital, LLC Hedge Fund•Event Driven | −$768.7K −68.6K shares |
UBS Group AG Institution | −$463.2K −24.1K shares |
Institutions that initiated new positions or completely exited ORKA in Q3 2025
| Institution | Position Value |
|---|---|
VIKING GLOBAL INVESTORS LP Hedge Fund•Long/Short | $51.3M 2.7M shares |
venBio Select Advisor LLC RIA/Wealth | $25.6M 1.3M shares |
C Cormorant Asset Management, LLC Hedge Fund•Long/Short | $10.3M 533.3K shares |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | $6.1M 316.9K shares |
R Resolute Capital Asset Partners LLC Hedge Fund•Long/Short | $1.4M 75.0K shares |
P Palo Alto Investors, LLC Hedge Fund•Long/Short | $791.3K 60.0K shares |
F Financial Enhancement Group LLC RIA/Wealth | $742.2K 32.8K shares |
A AMERICAN CENTURY COMPANIES INC Institution | $656.0K 34.1K shares |
SCHRODER INVESTMENT MANAGEMENT GROUP RIA/Wealth | $563.0K 29.2K shares |
Empirical Financial Services, LLC RIA/Wealth | $296.3K 15.4K shares |
| Institution | Previous Position |
|---|---|
Frazier Life Sciences Management, L.P. Venture Capital | $6.5M 583.3K shares |
SILVERARC CAPITAL MANAGEMENT, LLC Hedge Fund•Long/Short | $1.9M 165.4K shares |
Ikarian Capital, LLC Hedge Fund•Event Driven | $768.7K 68.6K shares |
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | $380.7K 34.0K shares |
BOOTHBAY FUND MANAGEMENT, LLC Fund of Funds | $213.0K 19.0K shares |
RENAISSANCE TECHNOLOGIES LLC Hedge Fund•Quant | $155.8K 13.9K shares |
MILLENNIUM MANAGEMENT LLC Hedge Fund•Multi-Strategy | $138.2K 12.3K shares |
$11.0 1.0 shares |
Institutions with the largest Call and Put options positions in ORKA as of Q3 2025
| Institution | Position Value |
|---|---|
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | $248.1K 129.0 contracts |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | $240.4K 125.0 contracts |
| Institution | Position Value |
|---|---|
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | $1.4M 726.0 contracts |
J JANE STREET GROUP, LLC Institution | $1.1M 562.0 contracts |
Caption Management, LLC Hedge Fund•Long/Short | $217.3K 113.0 contracts |
Institutions with ORKA as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
Cable Car Capital LLC Hedge Fund•Long/Short | 8.06% $9.6M |
Fairmount Funds Management LLC Hedge Fund•Sector | 6.41% $71.3M |
VR Adviser, LLC Venture Capital | 4.49% $79.8M |
A Avidity Partners Management LP Hedge Fund•Long/Short | 2.96% $12.7M |
Affinity Asset Advisors, LLC Hedge Fund•Long/Short | 1.88% $18.4M |
B B Group, Inc. Institution | 1.67% $1.4M |
COMMODORE CAPITAL LP Hedge Fund•Long/Short | 1.65% $33.7M |
G GREAT POINT PARTNERS LLC Private Equity | 1.55% $3.5M |
Deep Track Capital, LP Hedge Fund•Long/Short | 1.45% $51.1M |
SR ONE CAPITAL MANAGEMENT, LP Venture Capital | 1.20% $8.3M |
Discover hedge funds investing in ORKA

| Top Holding | Sector | Market Value | Weight |
|---|---|---|---|
Medical - Diagnostics & Research Healthcare | $259.5M | 7.38% | |
Biotechnology Healthcare | $249.1M | 7.08% | |
Biotechnology Healthcare | $236.3M | 6.72% |
We use cookies for analytics. See our Privacy and Cookie Policy.